Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies.

European journal of human genetics : EJHG - 1 Oct 2009

Zhang Zhizhong, Qiu Lixin, Wang Meilin, Tong Na, Li Jin, Zhang Zhengdong

Abstract excerpt

The potentially functional polymorphism, rs763110 (-844C>T), in the promoter region of the FAS ligand (FASL) gene, has been implicated in cancer risk, but individually published studies show inconclusive results. To derive a more precise estimation of the association between the FASL rs763110 and risk of cancer, we performed a meta-analysis of 19 published studies that included 11,105 cancer cases and 11,372...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fas Ligand Protein
Share to Heterozygote
Share to Models, Genetic
Share to Models, Statistical
Share to Neoplasms
Share to Odds Ratio
Share to Promoter Regions, Genetic
Share to Risk

Source

Open in PubMed Open full text

Identifiers

PMID: 19337311
DOI: 10.1038/ejhg.2009.45
PMCID: PMC2986648

Genes

FAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies.PMID 19337311Read ↗

FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.Semantic proximity Read ↗

Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.Semantic proximity Read ↗

FASLG polymorphism is associated with cancer risk.Semantic proximity Read ↗

FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.Semantic proximity Read ↗

The association between the SNP rs763110 and the risk of gynecological cancer: a meta-analysis.Semantic proximity Read ↗

Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.Semantic proximity Read ↗

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.Semantic proximity Read ↗

Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.Semantic proximity Read ↗

Association of Fas -1377 G/A polymorphism with susceptibility to cancer.Semantic proximity Read ↗

FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.Semantic proximity Read ↗

Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Association between the FAS rs2234767G/A polymorphism and cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.